TrialsgrambetaRCTs are beautiful

REVIVED-BCIS2

2022

REVascularization for Ischemic VEntricular Dysfunction — British Cardiovascular Intervention Society-2

In 700 patients with ischaemic LV dysfunction (LVEF ≤35%) and viable myocardium, PCI plus optimal medical therapy did not reduce all-cause death or HF hospitalisation compared with optimal medical therapy alone.

Result

Efficacy: Death from any cause or hospitalisation for heart failureHR 0.99 (95% CI 0.78-1.27) · P = 0.96

Below 1 favours PCI plus optimal medical therapy, above 1 favours optimal medical therapy alone.

Event rates
Absolute difference
0.8 points

The absolute difference is derived from the event rates.

Also reported: Neutral, with no difference in LVEF or quality of life. Median follow-up 41 months.

Original publication
Subtopic
PCI vs OMT
Design
Multicentre open-label RCT
Relevance
Important: one of several pillars.
Source
Perera D, et al. N Engl J Med. 2022;387(15):1351-60.doi 10.1056/NEJMoa2206606

Discussion & critique

Enrolled largely stable, minimally symptomatic patients selected for viability. Alongside STICH and ISCHEMIA, challenged the viability-guided revascularisation paradigm and downgraded routine PCI for ischaemic cardiomyopathy.

Discussed in podcasts